@ShahidNShah
How Will Insurers Cover A New Alzheimer's Drug?
Federal regulators have approved the first new drug for Alzheimer's disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment.
Healthcare experts expect broad coverage of the drug, which was approved Monday. But what that means for patients will vary widely depending on their insurance plan. In some cases, that could mean coming up with several thousand dollars to pay for what the insurer didn't cover.
And there's no guarantee that every case will be covered.
Here's what you need to know:
WHAT WAS APPROVED?
The Food and Drug Administration said it granted approval to a drug from Biogen based on clinical research results that seemed "reasonably likely" to benefit Alzheimer's patients.
It's the only drug that U.S. regulators have said can likely treat the underlying disease, rather than just manage symptoms. The new drug, which Biogen developed with Japan's Eisai Co., did not reverse mental decline. It slowed it in one study.
The FDA's decision came despite the conclusion of its advisory committee that there wasn't enough evidence that the drug slowed the brain-destroying disease.
Continue reading at modernhealthcare.com
Make faster decisions with community advice
- FDA Grants Accelerated Approval for Alzheimer’s Drug
- HIMSS21Europe: Vaccine hesitancy Is Associated With A Lack of Trust In Governments
- Innovations Should Improve Patient Experience, Reduce Burden On Workforce, CEOs say
- Is Cerner an Acquisition Target for Microsoft and Google?
- Is Gamification The Way Forward For Precision Health?
Next Article
-
Innovations Should Improve Patient Experience, Reduce Burden On Workforce, CEOs say
Calls for healthcare to do more to embrace technology as a means to improve care delivery must first address whether such changes add to or ease the burden of a workforce that's been beleaguered by …
Posted Jun 9, 2021 Healthcare Innovation Physician Burnout Patient Engagement